GPR31 and prostate carcinoma: Increasing evidence has suggested that GPR31 plays an important role in diverse pathophysiological processes, such as pancreatic development (36), atherosclerosis (37), prostate cancer (38), hepatocellular carcinoma (39), platelet activation, and arterial thrombosis (40).